Early research (Phase 1)Study completedNCT01546051What this trial is testingBCI-838 and Several BCI-632 Prodrugs in Healthy VolunteersWho this might be right forHealthy BrainCells Inc. 31
Early research (Phase 1)UnknownNCT03874130What this trial is testingScopolamine in Healthy VolunteersWho this might be right forMajor Depressive Disorder (MDD) Repurposed Therapeutics, Inc. 130
Early research (Phase 1)Study completedNCT01243957What this trial is testingMeasure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.Who this might be right forMajor Depressive Disorder Eli Lilly and Company 20
Early research (Phase 1)Study completedNCT01389752What this trial is testingEvaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsWho this might be right forDepressive Disorder, Major Eli Lilly and Company 22
Early research (Phase 1)Study completedNCT01263093What this trial is testingA Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelWho this might be right forMajor Depressive Disorder Eli Lilly and Company 47
Not applicableStudy completedNCT00931619What this trial is testingGABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major DepressionWho this might be right forEpilepsyEpilepsy, Temporal LobeDepression+1 more National Institute of Neurological Disorders and Stroke (NINDS) 29
Early research (Phase 1)Study completedNCT03357796What this trial is testingRelative Bioavailability (RBA) Study of LY03005 vs Pristiq®Who this might be right forMajor Depressive Disorder Luye Pharma Group Ltd. 20
Early research (Phase 1)Study completedNCT01275144What this trial is testingThe Effect of LY2216684 on LorazepamWho this might be right forMajor Depressive Disorder Eli Lilly and Company 28
Post-approval studies (Phase 4)Study completedNCT00704860What this trial is testingTreatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic PolymorphismWho this might be right forMajor Depression University of Ottawa 27
Not applicableStudy completedNCT00025974What this trial is testingBrain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress DisorderWho this might be right forPanic DisorderPosttraumatic Stress DisorderMajor Depressive Disorder National Institute of Mental Health (NIMH) 230
Early research (Phase 1)Study completedNCT01389765What this trial is testingEvaluate the Effect of Food on LY2216684Who this might be right forDepressive Disorder, Major Eli Lilly and Company 24
Not applicableStudy completedNCT00026832What this trial is testingExamination of Brain Serotonin Receptors in Patients With Mood DisordersWho this might be right forMood DisorderBipolar DisorderDepression National Institute of Mental Health (NIMH) 214
Not applicableStudy completedNCT04013464What this trial is testingEffects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive DisorderWho this might be right forDepressive Disorder, Major Peking University Sixth Hospital 31
Not applicableWithdrawnNCT01313403What this trial is testingImaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderWho this might be right forMajor DepressionUnipolar DepressionDepression+1 more National Institute of Mental Health (NIMH)
Early research (Phase 1)Not Yet RecruitingNCT07334249What this trial is testingFirst-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 InjectionWho this might be right forMajor Depressive Disorder, Healthy Volunteer Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. 80
Early research (Phase 1)Study completedNCT04711005What this trial is testingPhase 1 Evaluation of (2R,6R)-HydroxynorketamineWho this might be right forMajor Depressive Disorder National Institute of Mental Health (NIMH) 74
Early research (Phase 1)Study completedNCT04623034What this trial is testingEvaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-AdenosylmethionineWho this might be right forMajor Depressive Disorder MSI Methylation Sciences, Inc. 34
Early research (Phase 1)Study completedNCT05666687What this trial is testingAn Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the BrainWho this might be right forMajor Depressive Disorder Novartis Pharmaceuticals 10